Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans

被引:19
|
作者
Lo, Hsiu Jung [1 ,2 ]
Tseng, Kuo-Yun [1 ]
Kao, Yeong-Yi [3 ]
Tsao, Ming-Yang [1 ]
Lo, Han-Lun [3 ]
Yang, Yun-Liang [3 ,4 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan
[2] China Med Univ, Sch Dent, Taichung, Taiwan
[3] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan
[4] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan
关键词
Candida albicans; Drug resistance; Efflux pump; Virulence factor; Regulation; HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDRUG-RESISTANCE; ANTIFUNGAL AGENTS; EFFLUX PUMP; CDR1; FLUCONAZOLE; CONTRIBUTE; GENE; CEREVISIAE; EXPRESSION;
D O I
10.1016/j.ijantimicag.2015.01.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The cph1/cph1 efg1/efg1 double mutant in Candida albicans is defective in filamentous growth and is avirulent in a mouse model. We previously reported that Efg1p but not Cph1p is involved in drug resistance by negatively regulating ERG3 in C. albicans. In the current study, we have found that overexpression of 0411 in Saccharomyces cerevisiae increases susceptibility to the antifungal drug fluconazole. Furthermore, in C. albicans, null mutation of 0411 increased the expression of MDR1 as well as decreased susceptibility to fluconazole and voriconazole but not to amphotericin B. These findings indicate that although Efg1p and Cph1p may have the same effects on virulence, they have opposite effects on drug resistance in C. albicans. (C) 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:617 / 621
页数:5
相关论文
共 50 条
  • [21] HUMAN (MDR1) AND MOUSE (MDR1,MDR3) P-GLYCOPROTEINS CAN BE DISTINGUISHED BY THEIR RESPECTIVE DRUG-RESISTANCE PROFILES AND SENSITIVITY TO MODULATORS
    TANGWAI, DF
    KAJIJI, S
    DICAPUA, F
    DEGRAAF, D
    RONINSON, IB
    GROS, P
    BIOCHEMISTRY, 1995, 34 (01) : 32 - 39
  • [22] Reversal of MDR1/P-glycoprotein associated drug resistance in human Hepatoblastoma
    Warmann, Steven W.
    Fuchs, Joerg
    GENE THERAPY AND MOLECULAR BIOLOGY, 2008, 12B : 405 - 413
  • [23] MDR1 gene expression and drug resistance of AML cells
    Norgaard, JM
    Bukh, A
    Langkjer, ST
    Clausen, N
    Palshof, T
    Hokland, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (03) : 534 - 540
  • [24] MDR1: Role in clinical drug resistance and its reversal
    Sikic, BI
    ANNALS OF ONCOLOGY, 1998, 9 : 8 - 8
  • [25] Transcriptional regulation of MDR1, encoding a drug efflux determinant, in fluconazole-resistant Candida albicans strains through an Mcm1p binding site
    Riggle, Perry J.
    Kumamoto, Carol A.
    EUKARYOTIC CELL, 2006, 5 (12) : 1957 - 1968
  • [26] CaNdt80 is involved in drug resistance in Candida albicans by regulating CDR1
    Chen, CG
    Yang, YL
    Shih, HI
    Su, CL
    Lo, HJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4505 - 4512
  • [27] The role of Mdr1 in azole resistance in clinical isolates of Candida parapsilosis.
    Manigaba, Kayihura
    Berkov, Elizabeth
    Rogers, P. David
    PHARMACOTHERAPY, 2014, 34 (10): : E277 - E277
  • [28] MDR1-mediated drug resistance in Candida dubliniensis
    Wirsching, S
    Moran, GP
    Sullivan, DJ
    Coleman, DC
    Morschhäuser, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3416 - 3421
  • [29] Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans
    Xie, Fei
    Chang, Wenqiang
    Zhang, Ming
    Li, Ying
    Li, Wei
    Shi, Hongzhuo
    Zheng, Sha
    Lou, Hongxiang
    SCIENTIFIC REPORTS, 2016, 6
  • [30] Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans
    Fei Xie
    Wenqiang Chang
    Ming Zhang
    Ying Li
    Wei Li
    Hongzhuo Shi
    Sha Zheng
    Hongxiang Lou
    Scientific Reports, 6